TBC-3B live recombinant vaccinia virus vaccine containing the major components of HIV: NIAID is beginning a Phase I trial of the vaccine in 50 healthy volunteer

Therion Biologics Corp., Cambridge, Mass. Product: TBC-3B live recombinant vaccinia virus vaccine containing the major components of HIV, including matrix, core, envelope, reverse transcriptase, and o...